UNIVERSITY OF NEVADA, RENO

Home OCT Device Scanly Receives FDA Approval for Remote Monitoring of Retinal Diseases

5 months ago

• Notal Vision's Scanly, a patient self-operated home OCT device, has received FDA De Novo authorization for monitoring retinal diseases like nAMD. • Scanly allows for frequent at-home monitoring of retinal fluid, potentially providing eye care professionals with real-time insights into treatment effectiveness. • Clinical trials demonstrated high patient adherence and agreement between at-home Scanly images and in-office OCT scans, suggesting ease of use and reliability. • Experts believe home OCT could reduce treatment burden and enable more personalized care in ophthalmology, especially with the advent of longer-acting medications.